Illuccix
Payments companies reported to CMS as associated with Illuccix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Illuccix, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Illuccix
These are the largest totals companies reported as associated with Illuccix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaideep Sohi | Roseville, CA | Nuclear Radiology | $818,222.38 |
| Umesh Oza | Dallas, TX | Diagnostic Radiology | $128,582.99 |
| Amir Lavaf | Palm Springs, CA | Radiation Oncology | $117,375.46 |
| Paul Yonover | Chicago, IL | Urology | $112,009.63 |
| Brian Shuch | Los Angeles, CA | Urology | $100,034.01 |
| Robert Bridwell | Davis, WV | $55,074.40 | |
| John De Groot | Houston, TX | Neurology (Psychiatry & Neurology) | $46,382.16 |
| Munir Ghesani | Princeton, NJ | Nuclear Medicine | $46,066.93 |
| Sanoj Punnen | Miami, FL | Urology | $43,843.62 |
| Jeremie Calais | Los Angeles, CA | Nuclear Imaging & Therapy | $43,000.00 |
Prescribed Illuccix?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.